Related Experiment Video
Updated: Jan 2, 2026
08:43
A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
7.7K
Anterior knee schwannoma
Charmaine Ilagan1, Lauren Poliakin2, Armand Asarian2
1St. George's University School of Medicine, True Blue, Grenada, WI.
Journal of Surgical Case Reports
|December 7, 2019
Summary
Schwannomas, the most common peripheral nerve tumors, are typically benign and rarely become malignant. Diagnosis involves examination, imaging, and biopsy, with treatment tailored to symptoms and tumor location.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Peripheral nerve tumors are uncommon, with schwannomas representing the most frequent type.
- Schwannomas are generally benign, encapsulated neoplasms of Schwann cells, rarely exhibiting malignant transformation.
Observation:
- These tumors often present as solitary, incidentally discovered masses.
- Etiology is largely unknown; most cases are sporadic, but some link to genetic disorders like neurofibromatosis type 2.
- Schwannomas can manifest anywhere in the body, affecting all age groups, with peak incidence between 20-50 years.
Findings:
- Asymptomatic schwannomas are common, but symptomatic cases present with paresthesia or pain due to mass effect or nerve invasion.
- Diagnostic approaches integrate physical examination, advanced imaging (e.g., MRI), and surgical biopsy.
- Treatment strategies vary, ranging from conservative management for asymptomatic cases to surgical resection for symptomatic ones.
Implications:
- Early diagnosis and appropriate management of schwannomas are crucial for favorable patient outcomes.
- Understanding the pathogenesis and clinical presentation aids in differentiating benign schwannomas from other nerve pathologies.
- Surgical intervention for symptomatic schwannomas generally yields a positive prognosis, highlighting the importance of timely treatment.
